Rituximab anti-B-cell therapy in systemic lupus erythematosus: pointing to the future.
Purpose Of Review: To discuss the clinical effects and the immunologic consequences of transient B-cell depletion using the anti-CD20 monoclonal antibody rituximab in systemic lupus erythematosus.Recent Findings: A total of 100 rituximab-treated patients with severe disease, refractory to major immu...
| Published in: | Current Opinion in Rheumatology Vol. 17; no. 5; pp. 550 - 558 |
|---|---|
| Main Authors: | , , |
| Format: | research Journal Article |
| Published: |
Lippincott Williams & Wilkins
Sep2005
|
| Online Access: | View this record in EBSCOhost |